SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
49 hedge funds and large institutions have $251M invested in Syros Pharmaceuticals, Inc. Common Stock in 2017 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 26 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
9% more funds holding
Funds holding: 45 → 49 (+4)
Holders
49
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$16M | |
| 2 | +$6.73M | |
| 3 | +$5.96M | |
| 4 |
BlackRock
New York
|
+$5.88M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$4.77M |
Top Sellers
| 1 | -$5.57M | |
| 2 | -$1.81M | |
| 3 | -$1.01M | |
| 4 |
Millennium Management
New York
|
-$186K |
| 5 |
JPMorgan Chase & Co
New York
|
-$183K |